Amphastar製藥（NASDAQ:AMPH）報告其季度每股收益爲0.92美元，低於分析師預期的0.94美元，相差2.13%。這是其上一年同期每股收益0.88美元的基礎上增長了4.55%。該公司還報告季度銷售額爲1.865億美元，低於分析師預期的1.888億美元，相差1.22%。與去年同期1.78105億美元的銷售額相比，該季度銷售額增長了4.71%。

以上內容來自Benzinga Earnings專欄，原文如下：

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $0.94 by 2.13 percent. This is a 4.55 percent increase over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $186.500 million which missed the analyst consensus estimate of $188.810 million by 1.22 percent. This is a 4.71 percent increase over sales of $178.105 million the same period last year.